Nektar Therapeutics (NKTR)

Add to Watchlists

Create an Alert

Quickflows

20.17 -0.17 -0.84% NASDAQ Sep 18, 20:00 USD

Nektar Therapeutics News

Wire

Headline

Time (ET)
MT Newswires

Analyst Actions: JPMorgan Starts Nektar Therapeutics at Neutral With $26 Price Target

09/14 08:59
Yahoo

Nektar (NKTR) Down 12% Since Last Earnings Report: Can It Rebound?

09/05 11:32
MT Newswires

--Analyst Actions: SVB Leerink Cuts Nektar Therapeutics' Price Target to $17 From $18, Keeps at Market Perform

08/14 09:49
Yahoo

Did Hedge Funds Make The Right Call On Nektar Therapeutics (NKTR) ?

08/12 09:42
MT Newswires

Nektar Therapeutics, Vaccibody Dose First Patient in Study Evaluating Their Combination Drug for Cancer

08/12 08:58
PR Newswire

Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck

08/12 08:00
MT Newswires

Research Alert: CFRA Retains Sell Opinion On Nektar Therapeutics

08/07 15:10
Yahoo

Nektar's (NKTR) Q2 Earnings Beat, Bempeg Makes Progress

08/07 11:35
Yahoo

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

08/06 19:00
MT Newswires

-- Earnings Flash (NKTR) NEKTAR THERAPEUTICS Posts Q2 EPS $-0.45, vs. Street Est of $-0.69

08/06 16:23
MT Newswires

-- Earnings Flash (NKTR) NEKTAR THERAPEUTICS Posts Q2 Revenue $48.847M, vs. Street Est of $22.8M

08/06 16:22
PR Newswire

Nektar Therapeutics Reports Second Quarter 2020 Financial Results

08/06 16:15
Yahoo

If You Had Bought Nektar Therapeutics (NASDAQ:NKTR) Stock Five Years Ago, You Could Pocket A 106% Gain Today

08/05 11:15
Yahoo

Earnings Preview: Nektar Therapeutics (NKTR) Q2 Earnings Expected to Decline

07/30 12:33
PR Newswire

Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets

07/28 18:00
Yahoo

Hedge Funds Aren’t Impressed By Nektar Therapeutics (NKTR)

06/23 21:46
MT Newswires

Research Alert: CFRA Cuts View On Shares Of Nektar Therapeutics To Sell From Hold

06/10 09:25
MT Newswires

Nektar Therapeutics Says Study Shows Potential of Autoimmune Disease Drug Candidate

06/05 05:45
PR Newswire

Data Presented from Phase 1b Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology (EULAR 2020)

06/04 17:00
SA Breaking News

Nektar Therapeutics to host webcast on NKTR-358 data June 5

05/30 12:56

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.